M2-like macrophages transplantation protects against the doxorubicin-induced heart failure via mitochondrial transfer

Abstract

In our study, adoptive transfer of M2-like macrophages could protect against the doxorubicin-induced cardiotoxicity, which may be partly attributed to mitochondria transfer. And M2-like macrophages transplantation could become a treatment for non-ischemic heart failure in the clinical practice.